Transplant Complications Working Party (TCWP)
Study type:
Study number:
84110121
Type of Stem Cell Treatment:
Allogeneic
Diseases:
Short title:
Immune Checkpoint Inhibitors (ICI)
Primary objective:
Key inclusion criteria:
Country:
Principal investigator:
Jan Brijs
EBMT Study coordinator:
William Boreland
Study coordinator email:
william.boreland@ebmt.org